Long‐term remission in gout: Challenges and future opportunities
Rheumatology &Autoimmunity, EarlyView.Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley +1 more source
The causal relationship between antihypertensive drugs and knee osteoarthritis: A drug target Mendelian randomization study. [PDF]
Medicine (Baltimore)Li Z +6 more
europepmc +1 more source
Hypertension, antihypertensive drugs, and age at onset of Huntington's disease. [PDF]
Orphanet J Rare Dis, 2023 Zhu Y, Li M, Bai J, Wang H, Huang X.
europepmc +1 more source
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories [PDF]
, 2008 Bernard Vrijens +4 more
openalex +1 more source
Rheumatology &Autoimmunity, EarlyView.Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan +3 more
wiley +1 more source
Pharmacoepigenomic Impact of Antihypertensive Drugs on miRNome and Proteome and Its Potential Influence on Health and Side Effects. [PDF]
CellsBhass S, Banerjee M.
europepmc +1 more source
Improving the availability of antihypertensive drugs in the India Hypertension Control Initiative, India, 2019-2020. [PDF]
PLoS One, 2023 Kunwar A +7 more
europepmc +1 more source
Differences in Glucose Tolerance Between Fixed-Dose Antihypertensive Drug Combinations in People With Metabolic Syndrome [PDF]
, 2007 George L. Bakris
openalex +1 more source